Short-term Neonatal and Parental Outcomes in Low- and High-Risk Infants

April 10, 2026 updated by: Müşerref Ebru YALÇIN, Inonu University

Short Term Neonatal and Parents Outcomes in Low and High Risk Infants Undergoing Family Care Intervention

This study aimed to evaluate the short-term neonatal and parental outcomes in low- and high-risk infants following a single-session family care education intervention. A total of 34 parent-infant dyads were included.

All parents received a structured, family care education during hospitalization. Parental depression, anxiety, care participation, and neonatal pain were assessed on the 10th day of hospitalization and at discharge.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Afyonkarahisar, Turkey (Türkiye)
        • Afyonkarahisar Health Sciences University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

  • Infants diagnosed as neurodevelopmentally at risk.
  • Infants born between 37 and 40 gestational weeks.
  • Infants with a birth weight below 2500 grams.
  • Infants who have been admitted to the neonatal intensive care unit for at least 10 days since birth.

Exclusion Criteria:

  • Infants whose families declined participation in the study.
  • Infants with congenital anomalies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Family Care Intervention
A structured, family care education was provided to parents of hospitalized neonates. The session focused on promoting parental involvement in infant care, reducing parental anxiety and depression, and minimizing neonatal pain. The intervention was delivered individually to each parent-infant dyad during hospitalization and included guidance on routine neonatal care, recognizing and responding to infant cues, and supportive strategies for high-risk infants.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parental Care Participation
Time Frame: 1 year
In this study, the "Care Participation Assessment Scale for Mothers with Infants Hospitalized in the Neonatal Intensive Care Unit" was used to evaluate the level of maternal participation in the care of their infants. The scale consists of 19 items assessing caregiving practices performed by mothers. Each item is scored dichotomously (Yes/No), with "Yes" scored as 1 and "No" as 0. The total score ranges from 0 to 19, with higher scores indicating greater participation in infant care.
1 year
Edinburgh Postnatal Depression Scale
Time Frame: 1 year
In this study, the Edinburgh Postnatal Depression Scale was used to assess postpartum depressive symptoms. The scale consists of 10 items, each scored on a 4-point Likert scale (0-3). The total score ranges from 0 to 30, with higher scores indicating greater severity of depressive symptoms.
1 year
State-Trait Anxiety
Time Frame: 1 year
In this study, the State-Trait Anxiety Inventory was used to assess anxiety levels. The scale consists of two subscales: state anxiety (STAI-S) and trait anxiety (STAI-T), each comprising 20 items. Items are rated on a 4-point Likert scale, and total scores for each subscale range from 20 to 80, with higher scores indicating greater levels of anxiety.
1 year
Neonatal Pain
Time Frame: 1 year
In this study, the Neonatal Infant Pain Scale was used to assess pain in neonates. The scale consists of 6 items evaluating facial expression, cry, breathing patterns, arm and leg movements, and state of arousal. Each item is scored between 0 and 1, except for crying, which is scored between 0 and 2. The total score ranges from 0 to 7, with higher scores indicating greater pain intensity.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neurological Risk Level
Time Frame: 1 year
In this study, neurological risk level was assessed using the Dubowitz Neurological Examination. This standardized assessment evaluates neonatal neurological function, including tone, reflexes, movements, and behavioral responses. The total score ranges from 0 to 34, with higher scores indicating better neurological status and lower neurological risk.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Actual)

January 1, 2025

Study Completion (Actual)

January 1, 2025

Study Registration Dates

First Submitted

April 4, 2026

First Submitted That Met QC Criteria

April 10, 2026

First Posted (Actual)

April 16, 2026

Study Record Updates

Last Update Posted (Actual)

April 16, 2026

Last Update Submitted That Met QC Criteria

April 10, 2026

Last Verified

August 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • E-69996495-100-34196

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Risky Baby

Clinical Trials on Family Care Intervention

Subscribe